Save time and get answers to complex questions with AI chat
Mebendazole ingredients?Guselkumab loss of exclusitivy?Are there specific stretches to avoid while on lipitor?Patent expiration eu dabrafenib?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for irinotecan
Irinotecan (Camptosar, with the active ingredient irinotecan) received FDA approval on 16 October 1996. 1
The FDA approval date refers to the original approval of irinotecan under the brand name Camptosar. 1
You can verify the approval date and related drug information using DrugPatentWatch.com. 1
Other Questions About Irinotecan :
FDA approval on 16 October 1996